PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Current Liabilities data on file, last reported at $63.6 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 22.23% year-over-year to $63.6 million in Q1 2026; TTM through Mar 2026 was $63.6 million, a 22.23% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 23.83% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $63.6 million, down from $65.8 million in the prior quarter.
• Over the last five years, Total Current Liabilities for PRCT reached as high as $65.8 million in Q4 2025 and fell as low as $14.8 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $42.7 million across 5 years, with a median of $42.8 million in 2024.
• Across the five-year window, Total Current Liabilities surged 120.26% in 2023 and rose 0.47% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $35.3 million in 2022, then jumped by 30.14% to $45.9 million in 2023, then increased by 15.69% to $53.1 million in 2024, then advanced by 23.83% to $65.8 million in 2025, then slipped by 3.28% to $63.6 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $63.6 million in Q1 2026, $65.8 million in Q4 2025, and $53.9 million in Q3 2025.